Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 1 AL 15

Impressive reddish nodules with neoplastic-like appearance in a patient with Alzheimer's disease

Siragusa M, Lentini M, Schepis C.

Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):300-302. doi: 10.4103/ijdvl.IJDVL_226_19.

Reproducible Evaluation of Diffusion MRI Features for Automatic Classification of Patients with Alzheimer's Disease

Wen J, Samper-González J, Bottani S, Routier A, Burgos N, Jacquemont T, Fontanella S, Durrleman S, Epelbaum S, Bertrand A, Colliot O; Alzheimer’s Disease Neuroimaging Initiative.

Neuroinformatics. 2021 Jan;19(1):57-78. doi: 10.1007/s12021-020-09469-5.

Retinal Microvascular Alterations as the Biomarkers for Alzheimer Disease: Are We There Yet?

Jiang H, Wang J, Levin BE, Baumel BS, Camargo CJ, Signorile JF, Rundek T.

J Neuroophthalmol. 2021 Jun 1;41(2):251-260. doi: 10.1097/WNO.0000000000001140.

Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms

Armstrong GW, Kim LA, Vingopoulos F, Park JY, Garg I, Kasetty M, Silverman RF, Zeng R, Douglas VP, Lopera F, Baena A, Giraldo M, Norton D, Cronin-Golomb A, Arboleda-Velasquez JF, Quiroz YT, Miller JB.

JAMA Ophthalmol. 2021 Jan 1;139(1):49-56. doi: 10.1001/jamaophthalmol.2020.4909.

Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P)

Yang B, Yang S, Zhang Y, Liu W, Gan Y, Li Y, Jiang D, Luo Y, Zhao Q.

J Alzheimers Dis. 2021;79(1):141-152. doi: 10.3233/JAD-200652.

Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?

Flores-Cuadra JA, Madrid A, Fernández PL, Pérez-Lao AR, Oviedo DC, Britton GB, Carreira MB.

J Alzheimers Dis. 2021;82(s1):S227-S250. doi: 10.3233/JAD-200870.

Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer's disease

Rocha FL, de Vasconcelos Cunha UG, Paschoalin RC, Hara C, Thomaz DP.

Int Clin Psychopharmacol. 2021 Mar 1;36(2):104-105. doi: 10.1097/YIC.0000000000000334.

Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy

Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF.

J Alzheimers Dis. 2021;79(1):275-287. doi: 10.3233/JAD-200735.

Alzheimer's Disease and Face Masks in Times of COVID-19

Gil R, Arroyo-Anlló EM.

J Alzheimers Dis. 2021;79(1):9-14. doi: 10.3233/JAD-201233.

Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Musiek ES, Morris JC.

JAMA Neurol. 2021 Feb 1;78(2):141-142. doi: 10.1001/jamaneurol.2020.4478.

Effect of Antihypertensive Drugs on Cognition and Behavioral Symptoms of Patients with Alzheimer's Disease: A Meta-analysis

Rahimi R, Nikfar S, Sadeghi M, Abdollahi M, Moghaddam RH, Farzaei MH.

Curr Pharm Biotechnol. 2021;22(11):1511-1519. doi: 10.2174/1386207323666201211101720.

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease

Ettcheto M, Busquets O, Cano A, Sánchez-Lopez E, Manzine PR, Espinosa-Jimenez T, Verdaguer E, Sureda FX, Olloquequi J, Castro-Torres RD, Auladell C, Folch J, Casadesús G, Camins A.

J Alzheimers Dis. 2021;82(s1):S91-S107. doi: 10.3233/JAD-201106.

Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab

Klein G, Delmar P, Kerchner GA, Hofmann C, Abi-Saab D, Davis A, Voyle N, Baudler M, Fontoura P, Doody R.

J Prev Alzheimers Dis. 2021;8(1):3-6. doi: 10.14283/jpad.2020.68.

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease

Ng KP, Pascoal TA, Mathotaarachchi S, Chan YH, Jiang L, Therriault J, Benedet AL, Shin M, Kandiah N, Greenwood CMT, Rosa-Neto P, Gauthier S; Dominantly Inherited Alzheimer Network.

Transl Neurodegener. 2021 Jan 4;10(1):1. doi: 10.1186/s40035-020-00225-y.

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Largent EA, Wexler A, Karlawish J.

JAMA Neurol. 2021 Apr 1;78(4):379-380. doi: 10.1001/jamaneurol.2020.4835.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias